Cargando…
In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer
BACKGROUND: Magnetic Fluid Hyperthermia (MFH) is a promising adjuvant for chemotherapy, potentiating the action of anticancer agents. However, drug delivery to cancer cells must be optimized to improve the overall therapeutic effect of drug/MFH combination treatments. PURPOSE: The aim of this work w...
Autores principales: | Mérida, Fernando, Rinaldi, Carlos, Juan, Eduardo J, Torres-Lugo, Madeline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982443/ https://www.ncbi.nlm.nih.gov/pubmed/32021188 http://dx.doi.org/10.2147/IJN.S217870 |
Ejemplares similares
-
Development of handheld induction heaters for magnetic fluid hyperthermia applications and in-vitro evaluation on ovarian and prostate cancer cell lines
por: Castro-Torres, Jorge L, et al.
Publicado: (2023) -
Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines
por: Alvarez-Berríos, Merlis P, et al.
Publicado: (2013) -
Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles
por: Rodríguez-Luccioni, Héctor L, et al.
Publicado: (2011) -
Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia
por: LIU, JIAYI, et al.
Publicado: (2013) -
2-phenylethynesulfonamide inhibits growth of oral squamous cell carcinoma cells by blocking the function of heat shock protein 70
por: Jiang, Liang, et al.
Publicado: (2020)